First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

523 Reviews

Credit Rating - THEA PHARMACEUTICALS LIMITED

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: THEA PHARMACEUTICALS LIMITED, IC5 BUILDING INNOVATION WAY, KEELE, NEWCASTLE, ST5 5NT. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2022. The company was incorporated on 15 February 2008.

The accounts next due date is 30 September 2024. There is 1 mortgage, which is unsatisfied

The above was based on public record information as at 7 May 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 06505496
Date Incorporated: 15 February 2008
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: SPECTRUM THEA PHARMACEUTICALS LIMITED, SPECTRUM THEA LIMITED
Registered Number: 06505496
Annual Return: 15 February 2016
Registered Office: IC5 BUILDING INNOVATION WAY, KEELE, NEWCASTLE, ST5 5NT
SIC Code and Operations: 46460
SECURED CREDITORS
Number of Mortgages 1
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 1
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

THEA PHARMACEUTICALS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 17 May 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
14504464 THEA POWER LIMITED Active
10862155 THEA PRODUCTIONS LIMITED Active
11363547 THEA PROJECTS LIMITED Active
11399409 THEA PROPERTY LTD Active
09276147 THEA PROPERTY MANAGEMENT LIMITED Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd